Home > Research > Publications & Outputs > Cerebellar Volume and Disease Staging in Parkin...

Links

Text available via DOI:

View graph of relations

Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study. / the ENIGMA‐Parkinson's Study.
In: Movement Disorders, Vol. 38, No. 12, 31.12.2023, p. 2269-2281.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

the ENIGMA‐Parkinson's Study 2023, 'Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study', Movement Disorders, vol. 38, no. 12, pp. 2269-2281. https://doi.org/10.1002/mds.29611

APA

the ENIGMA‐Parkinson's Study (2023). Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study. Movement Disorders, 38(12), 2269-2281. https://doi.org/10.1002/mds.29611

Vancouver

the ENIGMA‐Parkinson's Study. Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study. Movement Disorders. 2023 Dec 31;38(12):2269-2281. Epub 2023 Nov 14. doi: 10.1002/mds.29611

Author

the ENIGMA‐Parkinson's Study. / Cerebellar Volume and Disease Staging in Parkinson's Disease : An ENIGMA‐PD Study. In: Movement Disorders. 2023 ; Vol. 38, No. 12. pp. 2269-2281.

Bibtex

@article{6b07753e48ec4f9b92c1bee905b984f1,
title = "Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD Study",
abstract = "BACKGROUND: Increasing evidence points to a pathophysiological role for the cerebellum in Parkinson's disease (PD). However, regional cerebellar changes associated with motor and non-motor functioning remain to be elucidated.OBJECTIVE: To quantify cross-sectional regional cerebellar lobule volumes using three dimensional T1-weighted anatomical brain magnetic resonance imaging from the global ENIGMA-PD working group.METHODS: Cerebellar parcellation was performed using a deep learning-based approach from 2487 people with PD and 1212 age and sex-matched controls across 22 sites. Linear mixed effects models compared total and regional cerebellar volume in people with PD at each Hoehn and Yahr (HY) disease stage, to an age- and sex- matched control group. Associations with motor symptom severity and Montreal Cognitive Assessment scores were investigated.RESULTS: Overall, people with PD had a regionally smaller posterior lobe (d max  = -0.15). HY stage-specific analyses revealed a larger anterior lobule V bilaterally (d max  = 0.28) in people with PD in HY stage 1 compared to controls. In contrast, smaller bilateral lobule VII volume in the posterior lobe was observed in HY stages 3, 4, and 5 (d max  = -0.76), which was incrementally lower with higher disease stage. Within PD, cognitively impaired individuals had lower total cerebellar volume compared to cognitively normal individuals (d = -0.17). CONCLUSIONS: We provide evidence of a dissociation between anterior {"}motor{"} lobe and posterior {"}non-motor{"} lobe cerebellar regions in PD. Whereas less severe stages of the disease are associated with larger motor lobe regions, more severe stages of the disease are marked by smaller non-motor regions. {\textcopyright} 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.",
keywords = "cerebellum, MRI, disease staging, Parkinson's disease",
author = "{the ENIGMA‐Parkinson's Study} and Rebecca Kerestes and Laansma, {Max A.} and Conor Owens‐Walton and Andrew Perry and {van Heese}, {Eva M.} and Sarah Al‐Bachari and Anderson, {Tim J.} and Francesca Assogna and Aventurato, {{\'I}talo K.} and {van Balkom}, {Tim D.} and Berendse, {Henk W.} and {van den Berg}, {Kevin R.E.} and Rebecca Betts and Ricardo Brioschi and Jonathan Carr and Fernando Cendes and Clark, {Lyles R.} and Dalrymple‐Alford, {John C.} and Dirkx, {Michiel F.} and Jason Druzgal and Helena Durrant and Emsley, {Hedley C.A.} and Ga{\"e}tan Garraux and Haroon, {Hamied A.} and Helmich, {Rick C.} and {van den Heuvel}, {Odile A.} and Jo{\~a}o, {Rafael B.} and Johansson, {Martin E.} and Khachatryan, {Samson G.} and Christine Lochner and McMillan, {Corey T.} and Melzer, {Tracy R.} and Mosley, {Philip E.} and Benjamin Newman and Peter Opriessnig and Parkes, {Laura M.} and Clelia Pellicano and Fabrizio Piras and Pitcher, {Toni L.} and Poston, {Kathleen L.} and Mario Rango and Annerine Roos and Christian Rummel and Reinhold Schmidt and Petra Schwingenschuh and Silva, {Lucas S.} and Viktorija Smith and Letizia Squarcina and Stein, {Dan J.} and Thompson, {Paul M.}",
year = "2023",
month = dec,
day = "31",
doi = "10.1002/mds.29611",
language = "English",
volume = "38",
pages = "2269--2281",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "Wiley",
number = "12",

}

RIS

TY - JOUR

T1 - Cerebellar Volume and Disease Staging in Parkinson's Disease

T2 - An ENIGMA‐PD Study

AU - the ENIGMA‐Parkinson's Study

AU - Kerestes, Rebecca

AU - Laansma, Max A.

AU - Owens‐Walton, Conor

AU - Perry, Andrew

AU - van Heese, Eva M.

AU - Al‐Bachari, Sarah

AU - Anderson, Tim J.

AU - Assogna, Francesca

AU - Aventurato, Ítalo K.

AU - van Balkom, Tim D.

AU - Berendse, Henk W.

AU - van den Berg, Kevin R.E.

AU - Betts, Rebecca

AU - Brioschi, Ricardo

AU - Carr, Jonathan

AU - Cendes, Fernando

AU - Clark, Lyles R.

AU - Dalrymple‐Alford, John C.

AU - Dirkx, Michiel F.

AU - Druzgal, Jason

AU - Durrant, Helena

AU - Emsley, Hedley C.A.

AU - Garraux, Gaëtan

AU - Haroon, Hamied A.

AU - Helmich, Rick C.

AU - van den Heuvel, Odile A.

AU - João, Rafael B.

AU - Johansson, Martin E.

AU - Khachatryan, Samson G.

AU - Lochner, Christine

AU - McMillan, Corey T.

AU - Melzer, Tracy R.

AU - Mosley, Philip E.

AU - Newman, Benjamin

AU - Opriessnig, Peter

AU - Parkes, Laura M.

AU - Pellicano, Clelia

AU - Piras, Fabrizio

AU - Pitcher, Toni L.

AU - Poston, Kathleen L.

AU - Rango, Mario

AU - Roos, Annerine

AU - Rummel, Christian

AU - Schmidt, Reinhold

AU - Schwingenschuh, Petra

AU - Silva, Lucas S.

AU - Smith, Viktorija

AU - Squarcina, Letizia

AU - Stein, Dan J.

AU - Thompson, Paul M.

PY - 2023/12/31

Y1 - 2023/12/31

N2 - BACKGROUND: Increasing evidence points to a pathophysiological role for the cerebellum in Parkinson's disease (PD). However, regional cerebellar changes associated with motor and non-motor functioning remain to be elucidated.OBJECTIVE: To quantify cross-sectional regional cerebellar lobule volumes using three dimensional T1-weighted anatomical brain magnetic resonance imaging from the global ENIGMA-PD working group.METHODS: Cerebellar parcellation was performed using a deep learning-based approach from 2487 people with PD and 1212 age and sex-matched controls across 22 sites. Linear mixed effects models compared total and regional cerebellar volume in people with PD at each Hoehn and Yahr (HY) disease stage, to an age- and sex- matched control group. Associations with motor symptom severity and Montreal Cognitive Assessment scores were investigated.RESULTS: Overall, people with PD had a regionally smaller posterior lobe (d max  = -0.15). HY stage-specific analyses revealed a larger anterior lobule V bilaterally (d max  = 0.28) in people with PD in HY stage 1 compared to controls. In contrast, smaller bilateral lobule VII volume in the posterior lobe was observed in HY stages 3, 4, and 5 (d max  = -0.76), which was incrementally lower with higher disease stage. Within PD, cognitively impaired individuals had lower total cerebellar volume compared to cognitively normal individuals (d = -0.17). CONCLUSIONS: We provide evidence of a dissociation between anterior "motor" lobe and posterior "non-motor" lobe cerebellar regions in PD. Whereas less severe stages of the disease are associated with larger motor lobe regions, more severe stages of the disease are marked by smaller non-motor regions. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

AB - BACKGROUND: Increasing evidence points to a pathophysiological role for the cerebellum in Parkinson's disease (PD). However, regional cerebellar changes associated with motor and non-motor functioning remain to be elucidated.OBJECTIVE: To quantify cross-sectional regional cerebellar lobule volumes using three dimensional T1-weighted anatomical brain magnetic resonance imaging from the global ENIGMA-PD working group.METHODS: Cerebellar parcellation was performed using a deep learning-based approach from 2487 people with PD and 1212 age and sex-matched controls across 22 sites. Linear mixed effects models compared total and regional cerebellar volume in people with PD at each Hoehn and Yahr (HY) disease stage, to an age- and sex- matched control group. Associations with motor symptom severity and Montreal Cognitive Assessment scores were investigated.RESULTS: Overall, people with PD had a regionally smaller posterior lobe (d max  = -0.15). HY stage-specific analyses revealed a larger anterior lobule V bilaterally (d max  = 0.28) in people with PD in HY stage 1 compared to controls. In contrast, smaller bilateral lobule VII volume in the posterior lobe was observed in HY stages 3, 4, and 5 (d max  = -0.76), which was incrementally lower with higher disease stage. Within PD, cognitively impaired individuals had lower total cerebellar volume compared to cognitively normal individuals (d = -0.17). CONCLUSIONS: We provide evidence of a dissociation between anterior "motor" lobe and posterior "non-motor" lobe cerebellar regions in PD. Whereas less severe stages of the disease are associated with larger motor lobe regions, more severe stages of the disease are marked by smaller non-motor regions. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

KW - cerebellum

KW - MRI

KW - disease staging

KW - Parkinson's disease

U2 - 10.1002/mds.29611

DO - 10.1002/mds.29611

M3 - Journal article

C2 - 37964373

VL - 38

SP - 2269

EP - 2281

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 12

ER -